TolerogenixX, a spin-off from the University of Heidelberg, offers a new approach to immunosuppression involving MIC cell therapy.

This is a curative ATMP approach to treatment that promotes sustainable regulation of the immune system in people who have received transplants or patients with autoimmune diseases.

tolerogenixx.com